Economy of New South Wales

Benitec Announces Supreme Court of Queensland Approval for Redomicile

Retrieved on: 
Monday, March 30, 2020

MELBOURNE, Australia, March 30, 2020 /PRNewswire/ --Benitec Biopharma Limited (Benitec or the "Company") (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland ("Court") has approved the scheme of arrangement to redomicile the Benitec group from Australia to the United States of America.

Key Points: 
  • MELBOURNE, Australia, March 30, 2020 /PRNewswire/ --Benitec Biopharma Limited (Benitec or the "Company") (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland ("Court") has approved the scheme of arrangement to redomicile the Benitec group from Australia to the United States of America.
  • Benitec has lodged an official copy of the Court orders with the Australian Securities and Investments Commission.
  • Benitec shares have been suspended from trading on ASX from the close of trading on Monday, March 30, 2020 (AEST).
  • Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is a clinical-stage biotechnology company focused on the development of novel genetic medicines.

Minister Duclos tables 2020-21 Departmental Plans

Retrieved on: 
Tuesday, March 10, 2020

Today, the Honourable Jean-Yves Duclos, President of the Treasury Board, tabled in the House of Commons the annual Departmental Plans on behalf of 88 government departments and agencies.

Key Points: 
  • Today, the Honourable Jean-Yves Duclos, President of the Treasury Board, tabled in the House of Commons the annual Departmental Plans on behalf of 88 government departments and agencies.
  • The 202021 Departmental Plans form the baseline against which organizations will track their performance throughout the year.
  • - The Honourable Jean-Yves Duclos, President of the Treasury Board
    Departmental Plans provide details on an organization's mandate, commitments and priorities.
  • Departmental Plans form the baseline against which organizations will track and report on their year-end performance through Departmental Results Reports, which replace the former Departmental Performance Reports.

Sydney Stock Exchange Announces New CEO, First Listing Applications

Retrieved on: 
Monday, December 16, 2019

The Sydney Stock Exchange (SSX), Australias alternative tier-one listing venue, announced its new CEO, Mr Michael Go, and strategy this week as it accepted its first listing applications from Australian cleantech energy company AGEO Resources and Australian medical technology company ANNSCA Medical.

Key Points: 
  • The Sydney Stock Exchange (SSX), Australias alternative tier-one listing venue, announced its new CEO, Mr Michael Go, and strategy this week as it accepted its first listing applications from Australian cleantech energy company AGEO Resources and Australian medical technology company ANNSCA Medical.
  • Mr Go said the SSXs first accepted listing application, AGEO Resources, was a perfect example of the exchanges new approach.
  • We are very much looking forward to listing next year and appreciate the support they have provided us.
  • We are different because we are focused on listing smaller companies; we have a six-week listing process; and we are the only Australian exchange with a dedicated ESG board.

Crown Group Releases Luxurious New Penthouse With Stunning Harbour View At Award-winning North Sydney Development

Retrieved on: 
Wednesday, November 20, 2019

Featuring spectacular view of the Sydney Harbour and private rooftop terrace and garden, the stunning penthouse offers luxurious and convenient urban resort lifestyle.

Key Points: 
  • Featuring spectacular view of the Sydney Harbour and private rooftop terrace and garden, the stunning penthouse offers luxurious and convenient urban resort lifestyle.
  • The new three-bedroom penthouse, with a combined area of 327sqm over two levels, captures views across Sydney Harbour, from every room.
  • Located at 211-223 Pacific Highway at North Sydney, Skye by Crown Group is six minutes' walk to North Sydney train station, 5km from the Sydney CBD and 20 minutes drive to Sydney airport.
  • Crown Group Holdings (Crown Group) is a leading Australian property group specialising in property development, property investment and serviced apartments.

Chalice Announces Voluntary De-Listing from Toronto Stock Exchange

Retrieved on: 
Friday, November 8, 2019

PERTH, Western Australia, Nov. 8, 2019 /CNW/ - Chalice Gold Mines Limited (ASX: CHN | TSX: CXN | OTCQB: CGMLF) ("Chalice" or the "Company") advises that it has applied for a voluntary de-listing of its ordinary shares ("shares") from trading on the Toronto Stock Exchange ("TSX").

Key Points: 
  • PERTH, Western Australia, Nov. 8, 2019 /CNW/ - Chalice Gold Mines Limited (ASX: CHN | TSX: CXN | OTCQB: CGMLF) ("Chalice" or the "Company") advises that it has applied for a voluntary de-listing of its ordinary shares ("shares") from trading on the Toronto Stock Exchange ("TSX").
  • No change will occur to the quotation and trading of Chalice shares on the Australian Securities Exchange ("ASX") and its shares will remain available for trading on the ASX under the code CHN.
  • In addition, the disposal in July 2019 of the Company's Canadian Projects to O3 Mining Inc. marked an exit of Chalice from Canada.
  • This strategic change has allowed Chalice to focus on its growing portfolio of Australian exploration projects.

Splitit Announces Chief Executive Officer Transition

Retrieved on: 
Thursday, September 19, 2019

SYDNEY, Sept. 19, 2019 /PRNewswire/ -- Splitit Payments Ltd (ASX: SPT) (Splitit or the Company), a leading global monthly installment payments solution business, announces that its Co-Founder, Gil Don, has decided to step down from his role as Chief Executive Officer, and will take up the position as General Manager, EMEA.

Key Points: 
  • SYDNEY, Sept. 19, 2019 /PRNewswire/ -- Splitit Payments Ltd (ASX: SPT) (Splitit or the Company), a leading global monthly installment payments solution business, announces that its Co-Founder, Gil Don, has decided to step down from his role as Chief Executive Officer, and will take up the position as General Manager, EMEA.
  • Mr. Don, who will remain on the Splitit Board, will be replaced as Chief Executive Officer by Brad Paterson, currently Splitit's Managing Director, North America.
  • Gil Don co-founded Splitit in 2009 with Alon Feit, Chief Risk Officer and a Director of the Company, and has led the business as Chief Executive Officer since 2015, including through its listing on the Australian Securities Exchange (ASX) in January 2019.
  • Brad joined Splitit in June 2019, following executive roles at some of the world's most successful payment and software companies, including Intuit, PayPal and Visa.

Sundance’s Board Unanimously Recommends Re-domiciliation and Listing in the United States

Retrieved on: 
Wednesday, September 11, 2019

If the Scheme of Arrangement is approved, the Company will transfer its primary listing to Nasdaq, and will cease to trade on the Australian Securities Exchange (ASX).

Key Points: 
  • If the Scheme of Arrangement is approved, the Company will transfer its primary listing to Nasdaq, and will cease to trade on the Australian Securities Exchange (ASX).
  • The Company intends to cancel its sponsored American Depositary Receipt program following the implementation of the Scheme.
  • Sundance Energy Australia Limited (Sundance or the Company) is an Australian-based, independent energy exploration company, with headquarters in Denver, Colorado, USA.
  • This press release does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction.

Mesoblast Corporate Update: Analyst Call

Retrieved on: 
Tuesday, September 10, 2019

NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, will provide a corporate update during an analyst call today.

Key Points: 
  • NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, will provide a corporate update during an analyst call today.
  • The webcast will begin at 8.30pm EDT Monday September 9, 2019; 10.30am AEST Tuesday September 10, 2019.
  • To access the call only, dial 1 855 881 1339 (U.S.), 1 800 558 698 (toll-free Australia) or +61 2 9007 3187 (outside of the U.S. and Australia).
  • Mesoblast has facilities in Melbourne, New York, Singapore and Texas and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO).

PointsBet Launches The Bad Beat Index - New Definitive Ranking for Sports Betting Bad Beats

Retrieved on: 
Tuesday, September 3, 2019

EXCHANGE PLACE, N.J., Sept. 3,2019 /PRNewswire/ -- PointsBet,a premier global sportsbook operator,announced today the creation of "The Bad Beat Index."

Key Points: 
  • EXCHANGE PLACE, N.J., Sept. 3,2019 /PRNewswire/ -- PointsBet,a premier global sportsbook operator,announced today the creation of "The Bad Beat Index."
  • The index will be published regularly HERE and will utilize PointsBet's leading, in-house technology and sports expertise to create the industry-wide, official rankings system for all bad beats.
  • The Bad Beat Index serves as the first and only quantifiable system providing metrics that determine the severity of bad beats for bettors.
  • PointsBet announced the company's Initial Public Offering on the Australian Securities Exchange on June 12, 2019.

Mesoblast to Host Analyst Call on 2019 Financial Results for Year and Fourth Quarter Ended June 30, 2019

Retrieved on: 
Tuesday, August 27, 2019

NEW YORK and MELBOURNE, Australia, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, will host a webcast to discuss the financial results for the period ending June 30, 2019.

Key Points: 
  • NEW YORK and MELBOURNE, Australia, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, will host a webcast to discuss the financial results for the period ending June 30, 2019.
  • The webcast will begin at 6.00pm EDT Thursday, August 29, 2019; 8.00am; AEST Friday, August 30, 2019.
  • The archived webcast will be available on the Investor page of the Companys website: www.mesoblast.com
    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a world leader in developing allogeneic (off-the-shelf) cellular medicines.
  • Mesoblast has facilities in Melbourne, New York, Singapore and Texas and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO).